Roche Holding AG-Genusschein
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$277.60avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($67.4M), Boston Common Asset Management, LLC ($15.7M) and Kennedy Capital Management LLC ($3.5M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 26,127 shares sold, net −26,127 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Aristotle Capital Management, LLC | 0.13% | Reduce -1.6% | 242,934 | $67.4M |
| Boston Common Asset Management, LLC | 0.40% | Reduce -28.1% | 56,437 | $15.7M |
| Kennedy Capital Management LLC | 0.07% | No change | 12,508 | $3.5M |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.